Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001371
Filing Date
2024-08-13
Accepted
2024-08-13 16:06:24
Documents
68
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zura-20240630x10q.htm   iXBRL 10-Q 1821724
2 EX-31.1 zura-20240630xex31d1.htm EX-31.1 9790
3 EX-31.2 zura-20240630xex31d2.htm EX-31.2 9804
4 EX-32.1 zura-20240630xex32d1.htm EX-32.1 5568
5 EX-32.2 zura-20240630xex32d2.htm EX-32.2 4720
  Complete submission text file 0001410578-24-001371.txt   7359175

Data Files

Seq Description Document Type Size
6 EX-101.SCH zura-20240630.xsd EX-101.SCH 66933
7 EX-101.CAL zura-20240630_cal.xml EX-101.CAL 34553
8 EX-101.DEF zura-20240630_def.xml EX-101.DEF 318894
9 EX-101.LAB zura-20240630_lab.xml EX-101.LAB 526444
10 EX-101.PRE zura-20240630_pre.xml EX-101.PRE 442196
71 EXTRACTED XBRL INSTANCE DOCUMENT zura-20240630x10q_htm.xml XML 979293
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40598 | Film No.: 241201405
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)